ALIMTA 500 MG 1 VIAL

* Each vial contains 500 mg of pemetrexed (as pemetrexed disodium).
& & – After reconstitution with 20 ml of sodium chloride 9 mg/ml (0.9%) solution for injection, each vial
& & contains 25 mg/ml of pemetrexed. Further dilution required prior to intravenous infusion (see package leaflet).
& & – List of excipients: Mannitol, hydrochloric acid, sodium hydroxide.
* Medicinal product subject to medical prescription.
* powder for concentrate for solution for infusion. For intravenous use after reconstitution && dilution.
* For single use only. Discard unused contents appropriately.
* Special precautions for storage:
& & – Unopened vial: This medicinal product does not require any special storage conditions.
& & Store below 25 degrees C – Excursions permitted up to 30 degrees C.
& & – Reconstituted and Infusion Solutions: When prepared as directed, reconstitution and infusion solutions of
& & ALIMTA contain no antimicrobial preservatives. Chemical and physical in-use stability of reconstituted and
& & and infusion solutions of pemetrexed were demonstrated for 24 hours at refrigerated temperature temperature
& & or 25 degrees C. From a microbiological point of view, the product should be used immediately. If not used
& & immediately, in-use storage times and conditions prior to use are the responsibility of the user and would
& & normally not be longer than 24 hours at 2 to 8 degrees C, unless reconstitution/dilution has taken place in
& & controlled and validated aseptic conditions.
* Manufactured by: Lilly France S.A.S. – France. استيراد: الكو